Showing results (51-60 of 90) with videos related to

Sort By:
Pageof 9
Annals of the Rheumatic Diseases|October 3, 2024
Comparison of definitions of early knee osteoarthritis for likelihood of progression at 2-year and 5-year follow-up: the Multicenter Osteoarthritis StudyJean W Liew, Eva Petrow, Sarah Tilley, et al.
Annals of the Rheumatic Diseases|August 5, 2025
Chondrocalcinosis and incident knee osteoarthritis: findings from 2 large prospective cohorts with 20 years of follow-upYahong Wu, Jean W Liew, Justin D Boer, et al.
The Journal of Rheumatology|December 2, 2021
The Association of Tumor Necrosis Factor Inhibitor Use With Incident Hypertension in Ankylosing Spondylitis: Data From the PSOAS CohortJean W Liew, S Reza Jafarzadeh, Maureen Dubreuil, et al.
European Journal of Rheumatology|February 14, 2022
Early impacts of the COVID-19 pandemic on children with pediatric rheumatic diseasesJonathan S Hausmann, Kevin Kennedy, Salman Surangiwala, et al.
Osteoarthritis and Cartilage|May 24, 2023
A scoping review of how early-stage knee osteoarthritis has been definedJean W Liew, Lauren K King, Armaghan Mahmoudian, et al.
Rheumatology (Oxford, England)|February 12, 2025
Comparative safety of biologic and targeted synthetic disease-modifying anti-rheumatic drugs for cardiovascular outcomes in rheumatoid arthritisXavier Sendaydiego, Laura S Gold, Maureen Dubreuil, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 19, 2024
Intra-Articular Mineralization on Computerized Tomography of the Knee and Risk of Cartilage Damage: The Multicenter Osteoarthritis StudyJean W Liew, Mohammed Jarraya, Ali Guermazi, et al.
Seminars in Arthritis and Rheumatism|June 12, 2024
The association of TNF inhibitor use with incident cardiovascular events in radiographic axial spondyloarthritisJean W Liew, Timothy Treu, Yojin Park, et al.
Arthritis Care & Research|October 28, 2024
Escalation to Biologics After Methotrexate Among US Veterans With Rheumatoid Arthritis Grouped by Rural Versus Urban AreasAnisha Naik, Aaron Baraff, Katherine D Wysham, et al.
JAMA Network Open|November 20, 2024
Use of Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drugs and Cancer RiskXavier Sendaydiego, Laura S Gold, Maureen Dubreuil, et al.
Pageof 9